
IndraLab
Statements
reach
"We show for the first time that in the presence of activated DNA damage checkpoint signaling, MDM2 acts to increase mutant p53 abundance, by facilitating monoubiquitination of mutant p53, and inactivation of checkpoint signaling serves as a switch that turns MDM2 from an activator of mutant p53 abundance to facilitating its degradation."
reach
"Meanwhile, other biomolecules such as a member of the anti-apoptotic factor Bcl-2 family (BGA2/BAG5), or the heat shock protein family (Hsp40, Hsp70 and Hsp90), are involved to regulate mutant p53 stability, for example, E3 ubiquitin ligase MDM2 and Hsp70 induce conformational changes in mutant p53 cells, and Hsp90 is recruited by BGA2 to assemble in the mutant p53 status (Wiech et al., 2012; Yue et al., 2016)."
reach
"Persistence of chemotherapy induced DNA damage has been observed in wild-type p53 glioblastoma cells [XREF_BIBR] as well as p53 deleted or mutant p53 ovarian cells [XREF_BIBR] treated with the first generation MDM2 antagonist Nutlin3a and this correlated with increases in MDM2 expression and cell death."
reach
"RNA interference showed that p53 knockdown increased the protein level of Gli1 but decreased the level of MDM2, and enhanced cell invasion and migration in wild-type p53 Capan-2 cells; whereas Gli1 or MDM2 knockdown did not change p53 expression, but decreased the protein level of MDM2 or Gli1, respectively, and inhibited cell invasion and migration in mutant p53 PANC-1 cells."
reach
"A number of natural products have been developed to target the p53-MDM2 pathway by 1) inhibiting MDM2 expression or protein stability, 2) inhibiting the p53-MDM2 interaction, 3) inhibiting the E3 ligase activity of MDM2, 4) reactivating or reinstating the wild-type functions of mutant p53, and/or 5) inhibiting the expression or protein stability of mutant p53."